PT3411014T - Novas composições tópicas compreendendo ácido úsnico e sua utilização em terapia - Google Patents

Novas composições tópicas compreendendo ácido úsnico e sua utilização em terapia

Info

Publication number
PT3411014T
PT3411014T PT177085834T PT17708583T PT3411014T PT 3411014 T PT3411014 T PT 3411014T PT 177085834 T PT177085834 T PT 177085834T PT 17708583 T PT17708583 T PT 17708583T PT 3411014 T PT3411014 T PT 3411014T
Authority
PT
Portugal
Prior art keywords
therapy
topical compositions
usnic acid
new topical
new
Prior art date
Application number
PT177085834T
Other languages
English (en)
Original Assignee
Apharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apharm Srl filed Critical Apharm Srl
Publication of PT3411014T publication Critical patent/PT3411014T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT177085834T 2016-02-04 2017-02-02 Novas composições tópicas compreendendo ácido úsnico e sua utilização em terapia PT3411014T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000024A ITUB20160024A1 (it) 2016-02-04 2016-02-04 Nuove composizioni topiche comprendenti acido usnico e loro uso in terapia.

Publications (1)

Publication Number Publication Date
PT3411014T true PT3411014T (pt) 2021-07-02

Family

ID=55969203

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177085834T PT3411014T (pt) 2016-02-04 2017-02-02 Novas composições tópicas compreendendo ácido úsnico e sua utilização em terapia

Country Status (5)

Country Link
EP (1) EP3411014B1 (pt)
ES (1) ES2880437T3 (pt)
IT (1) ITUB20160024A1 (pt)
PT (1) PT3411014T (pt)
WO (1) WO2017134594A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3858822B1 (en) 2018-10-10 2025-01-15 Seoul National University Hospital Usnic acid derivative having ability to inhibit tslp secretion, and use thereof
KR102561257B1 (ko) * 2018-10-10 2023-07-31 서울대학교병원 Tslp 분비 억제능을 갖는 우스닉산 유도체 및 이를 함유하는 알러지성 질환의 예방 또는 치료용 조성물
CN114469856B (zh) * 2022-01-20 2023-01-31 北京生泰尔科技股份有限公司 一种松萝酸钠溶液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1374903T3 (da) * 2002-06-26 2007-07-30 Innovet Italia Srl Farmaceutisk sammensætning til forebyggelse af udvikling og progression af mykotiske hudoverfladesygdomme
WO2012049677A2 (en) * 2010-10-10 2012-04-19 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
EP2691076A1 (en) * 2011-03-31 2014-02-05 Evocutis plc Usnic acid topical formulation

Also Published As

Publication number Publication date
EP3411014B1 (en) 2021-04-14
ES2880437T3 (es) 2021-11-24
EP3411014A1 (en) 2018-12-12
WO2017134594A1 (en) 2017-08-10
ITUB20160024A1 (it) 2017-08-04

Similar Documents

Publication Publication Date Title
IL253066A0 (en) Cannabis-based extracts and formulations for topical administration for use in the treatment of skin diseases
IL235923B (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
GB201511382D0 (en) Novel compounds and their use in therapy
GB201319620D0 (en) Immunosuppressive agents and their use in therapy
PL2956471T3 (pl) Kompozycja inhibitora il-1beta i jej zastosowanie
IL244901A0 (en) Derivatives of aminotetralin and aminoindan, pharmaceutical compositions containing them and their use in therapy
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
GB201604213D0 (en) Drug combination and its use in therapy
IL252739A0 (en) New complexes of nocardamine with metals and their uses in pharmaceutical compositions
HUE056401T2 (hu) Topikális készítmények és kezelések
GB201507723D0 (en) Anti-bacterial agents and their use in therapy
GB201507722D0 (en) Anti-bacterial agents and their use in therapy
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
PL3129057T3 (pl) Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu
PT3411014T (pt) Novas composições tópicas compreendendo ácido úsnico e sua utilização em terapia
IL245015A0 (en) Medicinal composition containing icotinib for topical treatment of the skin and its use
PT3373976T (pt) Formulações tópicas e suas utilizações
PL3325478T3 (pl) Nowy związek terapeutyczny i zastosowanie w terapii
PL3250181T3 (pl) Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw
GB2569682B (en) Topical composition for use in the treatment of burns
GB202201845D0 (en) Topical composition and delivery system and its use
GB201621390D0 (en) Novel compositions having use in therapy
GB201600570D0 (en) Novel compositions having use in therapy
AU2013901916A0 (en) An Agent and Use Thereof in Therapy
GB201409978D0 (en) Novel compounds and their use in therapy